Neurol. praxi. 2021;22(2):100-103 | DOI: 10.36290/neu.2020.107

Limb-girdle muscular dystrophies

doc. RNDr. Lenka Fajkusová, CSc., Mgr. Jana Zídková, Ph.D.
Centrum molekulární biologie a genové terapie, Fakultní nemocnice Brno

Limb-Girdle Muscular Dystrophies (LGMD) are a clinically and genetically heterogeneous group of diseases. To date, 29 genes associated with LGMD have been identified that divide LGMD into 29 subtypes. About 10 % of LGMD have a dominant type of inheritance, 90 % of LGMD have a recessive type of inheritance. The individual LGMD subtypes do not share a common pathophysiological mechanism of the disease that would distinguish them from other forms of muscular dystrophies. On the contrary, LGMD are associated with genes whose protein products have different functions and cellular localizations. Due to the number of associated genes, molecular genetic diagnosis of LGMD is a relatively complicated process, which is currently based on Next-Generation Sequencing (NGS) techniques both at the panel level of selected genes and at the whole exom level.

Keywords: neuromuscular diseases, lim-girdle muscular dystrophies, LGMD, NGS.

Received: October 2, 2020; Revised: October 23, 2020; Accepted: October 27, 2020; Prepublished online: October 27, 2020; Published: April 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fajkusová L, Zídková J. Limb-girdle muscular dystrophies. Neurol. praxi. 2021;22(2):100-103. doi: 10.36290/neu.2020.107.
Download citation

References

  1. Angelini C, Giaretta L, Marozzo R. An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 2018; 18(9): 693-703. Go to original source... Go to PubMed...
  2. Endo T. Glycobiology of alpha-dystroglycan and muscular dystrophy. J Biochem 2015; 157(1): 1-12. Go to original source... Go to PubMed...
  3. Chu ML, Moran E. The Limb-Girdle Muscular Dystrophies: Is Treatment on the Horizon? Neurotherapeutics 2018; 15(4): 849-862. Go to original source... Go to PubMed...
  4. Jokela M, Lehtinen S, Palmio J, Saukkonen AM, Huovinen S, Vihola A, Udd B. A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy. J Neurol 2019; 266(7): 1649-1654. Go to original source... Go to PubMed...
  5. Lemmers RJ, de Kievit P, Sandkuijl L, Padberg GW, van Ommen GJ, Frants RR, van der Maarel SM. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002; 32(2): 235-236. Go to original source... Go to PubMed...
  6. Liewluck T, Milone M. Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 2018; 58(2): 167-177. Go to original source... Go to PubMed...
  7. Murphy AP, Straub V. The Classification, Natural History and Treatment of the Limb Girdle Muscular Dystrophies. J Neuromuscul Dis 2015; 2(s2): S7-S19. Go to original source... Go to PubMed...
  8. Nigro V, Savarese M. Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 2014; 33(1): 1-12. Go to PubMed...
  9. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C, Hillaire D, Passos-Bueno MR, Zalz M, Tischfield JA, Fardeou M, Jackson CE, Cohen D, Beckmann JS. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81(1): 27-40. Go to original source... Go to PubMed...
  10. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, Committee ALQA. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17(5): 405-424. Go to original source... Go to PubMed...
  11. Straub V, Murphy A, Udd B and L. w. s. group. 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017. Neuromuscul Disord 2018; 28(8): 702-710. Go to original source... Go to PubMed...
  12. Thompson R, Straub V. Limb-girdle muscular dystrophies - international collaborations for translational research. Nat Rev Neurol 2016; 12(5): 294-309. Go to original source... Go to PubMed...
  13. Vissing J, Barresi R, Witting N, Van Ghelue M, Gammelgaard L, Bindoff LA, Straub V, Lochmuller H, Hudson J, Wahl CM, Arnardottir S, Dahlbom K, Jonsrud C, Duno M. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy. Brain 2016; 139(Pt 8): 2154-2163. Go to original source... Go to PubMed...
  14. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954; 77(2): 169-231. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.